Dr. Hiroki Shirai, former executive fellow at Astellas Pharma Inc. (currently affiliated at RIKEN), appointed as our Science Advisor
Accelerating theoretical R&D of therapeutic functional antibodies through machine learning and molecular modeling
On September 1, 2022, NB Health Laboratory Co Ltd signed a Science Advisory Agreement with Dr. Hiroki Shirai, former executive fellow at Astellas Pharma Inc. (currently affiliated at RIKEN), who is an expert in protein data science.
Dr. Shirai is one of leading experts in protein data science, particularly in antibody bioinformatics. He has experience in achieving the best results in international competitions for antibody structure prediction. Also, he has global network in the protein data science field and has established a worldwide industry-academia collaboration scheme in the same field. He is currently active as the coordinator at the Office of “Fugaku” Society 5.0 Initiative at the RIKEN Center for Computational Science, Vice President of the Protein Science Society of Japan, and associate professor at the University of Tsukuba.
With the participation of Dr. Shirai, we will further accelerate the development of our theoretical anti-GPCR antibody medicine (MoGRAA). In addition, we will actively apply big data and AI technology to our drug discovery research.